Claritev EBITDA Margin 2019-2025 | CTEV

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Claritev (CTEV) over the last 10 years. The current EBITDA margin for Claritev as of March 31, 2025 is .
Claritev EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $0.93B $-0.44B -47.84%
2024-12-31 $0.93B $-0.94B -101.29%
2024-09-30 $0.94B $-0.86B -91.40%
2024-06-30 $0.96B $-0.49B -50.89%
2024-03-31 $0.96B $0.07B 6.98%
2023-12-31 $0.96B $0.60B 62.27%
2023-09-30 $0.96B $-0.06B -6.26%
2023-06-30 $0.97B $-0.07B -6.94%
2023-03-31 $1.02B $0.00B -0.29%
2022-12-31 $1.08B $0.06B 5.84%
2022-09-30 $1.14B $0.80B 69.98%
2022-06-30 $1.17B $0.85B 72.74%
2022-03-31 $1.16B $0.85B 72.93%
2021-12-31 $1.12B $0.81B 72.61%
2021-09-30 $1.07B $0.65B 60.24%
2021-06-30 $1.01B $0.34B 33.76%
2021-03-31 $0.94B $0.27B 28.48%
2020-12-31 $0.94B $0.27B 28.89%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.620B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.108B 58.66
Hims & Hers Health (HIMS) United States $12.792B 132.91
Tempus AI (TEM) United States $12.331B 0.00
IRhythm Technologies (IRTC) United States $4.644B 0.00
Inspire Medical Systems (INSP) United States $3.793B 59.27
Privia Health (PRVA) United States $2.768B 189.17
Hinge Health (HNGE) United States $2.732B 0.00
Enovis (ENOV) United States $1.845B 10.28
Schrodinger (SDGR) United States $1.676B 0.00
Phreesia (PHR) United States $1.584B 0.00
Clover Health Investments (CLOV) United States $1.491B 0.00
Omnicell (OMCL) United States $1.403B 24.74
Azenta (AZTA) United States $1.392B 64.70
10x Genomics (TXG) United States $1.303B 0.00
Fulgent Genetics (FLGT) United States $0.639B 0.00
Butterfly Network (BFLY) United States $0.603B 0.00
Talkspace (TALK) United States $0.502B 150.00
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
Outset Medical (OM) United States $0.359B 0.00
TruBridge (TBRG) United States $0.357B 792.33
Health Catalyst (HCAT) United States $0.277B 0.00
Nyxoah SA (NYXH) Belgium $0.258B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.193B 0.00
KORU Medical Systems (KRMD) United States $0.148B 0.00
Pulmonx (LUNG) United States $0.126B 0.00
EUDA Health Holdings (EUDA) Singapore $0.126B 0.00
American Well (AMWL) United States $0.112B 0.00
MDxHealth SA (MDXH) Belgium $0.101B 0.00
CareCloud (CCLD) United States $0.091B 3.48
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Zhongchao (ZCMD) China $0.033B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00